CAM
ANAB icon

Cresset Asset Management’s AnaptysBio ANAB Stock Holding History

Cresset Asset Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$973K Buy
14,412
+544
+4% +$33K ﹤0.01% 923
2026
Q1 		$769K Sell
13,868
-1,253
-8% -$67.4K ﹤0.01% 890
2025
Q4 		$733K Sell
15,121
-632
-4% -$24.6K ﹤0.01% 919
2025
Q3 		$482K Buy
15,753
+2,720
+21% +$62.4K ﹤0.01% 1036
2025
Q2 		$289K Sell
13,033
-1,580
-11% -$33.1K ﹤0.01% 1145
2025
Q1 		$272K Buy
+14,613
New +$244K ﹤0.01% 1369
2024
Q4 		– Sell
-10,591
Closed -$355K – 1777
2024
Q3 		$355K Sell
10,591
-456
-4% -$15.6K ﹤0.01% 1720
2024
Q2 		$277K Buy
+11,047
New +$257K ﹤0.01% 1756

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Cresset Asset Management's ANAB Position: Q2 2026 in Review

Cresset Asset Management increased its AnaptysBio (ANAB) stake by 3.9% in Q2 2026, buying an estimated $33K and bringing the position to 14,412 shares worth $973K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

Cresset Asset Management first reported a position in ANAB in Q2 2024 and has held it in 8 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Cresset Asset Management held 14,412 shares of AnaptysBio worth $973K as of Q2 2026.
  • Cresset Asset Management bought 544 AnaptysBio shares in Q2 2026, an estimated $33K.
  • AnaptysBio made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #923 holding.
  • Cresset Asset Management first reported a position in AnaptysBio in Q2 2024 and has held it in 8 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.